Amitabh Chandra

Henry and Allison McCance Professor of Business Administration at Harvard Business School, and the Ethel Zimmerman Wiener Professor of Public Policy and director of health policy research at the Harvard Kennedy School
Amitabh Chandra

Amitabh Chandra

Henry and Allison McCance Professor of Business Administration at Harvard Business School, and the Ethel Zimmerman Wiener Professor of Public Policy and director of health policy research at the Harvard Kennedy School

Biography

Amitabh Chandra is the Henry and Allison McCance Professor of Business Administration at Harvard Business School, and the Ethel Zimmerman Wiener Professor of Public Policy and director of health policy research at the Harvard Kennedy School.

Professor Chandra is a member of the Congressional Budget Office’s (CBO’s) panel of health advisors and a research associate at the National Bureau of Economic Research (NBER). His research focuses on innovation and pricing in the biopharmaceutical industry, value in health care, medical malpractice, and racial disparities in health care. His work has been supported by the National Institute on Aging, the National Institute of Child Health and Human Development, and the Robert Wood Johnson Foundation; and has been published in American Economic Review, the Journal of Political Economy, The New England Journal of Medicine, JAMA, and Health Affairs; and featured in The New York Times, The Washington Post, and Newsweek, as well as on CNN and NPR.

Professor Chandra has testified before the US Senate and the US Commission on Civil Rights. He has consulted to the RAND Corporation, Microsoft Research, and the Blue Cross Blue Shield Foundation of Massachusetts. In 2011, he served as Massachusetts’ Special Commissioner on Provider Price Reform.

Professor Chandra is an elected member of the National Academy of Medicine, and the recipient of the Upjohn Institute’s Dissertation Award, the NIHCM Foundation Health Care Research Award, the International Health Economics Association’s Kenneth J. Arrow Award for best paper in health economics, and the Eugene Garfield Award for the impact of medical research. In 2012, he was awarded American Society of Health Economists (ASHEcon) Medal, awarded biennially to the economist age 40 or under who has made the most significant contributions to the field of health economics.

Bio last updated in June 2021.